CD5 and B-cell chronic lymphocytic leukemia: In detail, in PBMC from two B-CLL patients (P1 and P2) we observed an average reduction of about 25% of membrane-bound CD5 protein levels following PNA treatment with respect to cells treated with scrambled PNA.